New research highlights a significant link between metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ...

Rates of chronic liver disease during pregnancy are rising partly due to MASLD and the downward trend of chronic viral hepatitis.

Fatty liver disease, now termed MASLD, often presents subtle abdominal symptoms like bloating and discomfort, even before ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis (MASH), is the most common aetiology of liver disease worldwide. MASLD is ...

Researchers from the Roger Williams Institute of Liver Studies at King's College London developed two 3D models from human ...

DEAR DR. ROACH: I am a 52-year-old woman who was diagnosed with familial hypercholesterolemia in October 2024. I went through a cardiac workup for pain in my left arm and found this out.

Dr Kolawole Akande, a consultant gastroenterologist at the University College Hospital (UCH) in Ibadan, in this interview with SADE OGUNTOLA, explains excessive fat in the liver as a dangerous ...

Although Wegovy (semaglutide) is often used as a weight-loss medicine, it is well-known to be protective for the heart. Similarly, telmisartan is in the class of drugs that protect the heart, even in ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious ...

The approval was based on Part 1 (72 week data) of the randomized, double-blind, placebo-controlled phase 3 ESSENCE trial.

Often symptomless, fatty liver disease is becoming a leading cause of liver cancer. Learn the role of daily habits, early ...